Matthew Roughley

429 total citations
8 papers, 274 citations indexed

About

Matthew Roughley is a scholar working on Psychiatry and Mental health, Clinical Psychology and Molecular Biology. According to data from OpenAlex, Matthew Roughley has authored 8 papers receiving a total of 274 indexed citations (citations by other indexed papers that have themselves been cited), including 4 papers in Psychiatry and Mental health, 3 papers in Clinical Psychology and 2 papers in Molecular Biology. Recurrent topics in Matthew Roughley's work include Schizophrenia research and treatment (4 papers), Obsessive-Compulsive Spectrum Disorders (2 papers) and Gout, Hyperuricemia, Uric Acid (2 papers). Matthew Roughley is often cited by papers focused on Schizophrenia research and treatment (4 papers), Obsessive-Compulsive Spectrum Disorders (2 papers) and Gout, Hyperuricemia, Uric Acid (2 papers). Matthew Roughley collaborates with scholars based in United Kingdom, India and Germany. Matthew Roughley's co-authors include Christian Mallen, John Belcher, Edward Roddy, Alyshah Abdul Sultan, Lorna Clarson, Sara Müller, Rebecca Whittle, James Chappell, M Snyder and Kazuya Miyagawa and has published in prestigious journals such as Circulation Research, Neuroscience & Biobehavioral Reviews and British Journal of Clinical Pharmacology.

In The Last Decade

Matthew Roughley

7 papers receiving 263 citations

Peers — A (Enhanced Table)

Peers by citation overlap · career bar shows stage (early→late) cites · hero ref

Name	h						Papers	Cites
Matthew Roughley United Kingdom	5	184	96	66	65	54	8	274
Linda Kao United States	5	99 0.5×	33 0.3×	51 0.8×	21 0.3×	24 0.4×	7	248
Benjamin Xu China	7	65 0.4×	23 0.2×	26 0.4×	28 0.4×	25 0.5×	15	158
Yi-Tong Ma China	11	63 0.3×	114 1.2×	43 0.7×	33 0.5×	10 0.2×	33	363
Ewelina Łukaszyk Poland	7	46 0.3×	26 0.3×	24 0.4×	42 0.6×	25 0.5×	9	207
Anca Gal‐Moscovici Israel	11	247 1.3×	37 0.4×	41 0.6×	47 0.7×	18 0.3×	21	370
Rosa Maria Parlongo Italy	9	127 0.7×	53 0.6×	69 1.0×	9 0.1×	19 0.4×	13	310
Sarah Triem Germany	3	197 1.1×	51 0.5×	67 1.0×	33 0.5×	17 0.3×	3	315
Jim Lash United States	7	251 1.4×	62 0.6×	55 0.8×	71 1.1×	15 0.3×	7	384
Maria Rita Sala Italy	8	194 1.1×	64 0.7×	65 1.0×	32 0.5×	28 0.5×	17	357
Rongjiong Zheng China	6	59 0.3×	32 0.3×	50 0.8×	21 0.3×	13 0.2×	12	315

Countries citing papers authored by Matthew Roughley

Since Specialization

Citations

This map shows the geographic impact of Matthew Roughley's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Matthew Roughley with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Matthew Roughley more than expected).

Fields of papers citing papers by Matthew Roughley

Since Specialization

Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Matthew Roughley. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Matthew Roughley. The network helps show where Matthew Roughley may publish in the future.

Co-authorship network of co-authors of Matthew Roughley

This figure shows the co-authorship network connecting the top 25 collaborators of Matthew Roughley. A scholar is included among the top collaborators of Matthew Roughley based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Matthew Roughley. Matthew Roughley is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

Sort: Min cites: Since: Top N: Style:

8 of 8 papers shown

1.

Roughley, Matthew, et al.. (2023). Guiding safer risperidone prescribing in Alzheimer's disease with therapeutic drug monitoring. British Journal of Clinical Pharmacology. 89(7). 2316–2321. 3 indexed citations

2.

Gould, Rebecca L., Matthew Roughley, Gemma Reynolds, et al.. (2022). Paranoid and misidentification subtypes of psychosis in dementia. Neuroscience & Biobehavioral Reviews. 134. 104529–104529. 6 indexed citations

3.

Roughley, Matthew, et al.. (2020). Referral of patients with emotionally unstable personality disorder for specialist psychological therapy: why, when and how?. BJPsych Bulletin. 45(1). 52–58. 4 indexed citations

4.

Hennigs, Jan K., Aiqin Cao, Caiyun G. Li, et al.. (2020). PPARγ-p53-Mediated Vasculoregenerative Program to Reverse Pulmonary Hypertension. Circulation Research. 128(3). 401–418. 58 indexed citations

5.

Roughley, Matthew, et al.. (2019). Republished: Retrograde ejaculation associated with quetiapine and treatment with low-dose imipramine. Drug and Therapeutics Bulletin. 57(12). 189–191.

6.

Roughley, Matthew, et al.. (2019). Retrograde ejaculation associated with quetiapine and treatment with low-dose imipramine. BMJ Case Reports. 12(8). e228539–e228539. 5 indexed citations

7.

Roughley, Matthew, Alyshah Abdul Sultan, Lorna Clarson, et al.. (2018). Risk of chronic kidney disease in patients with gout and the impact of urate lowering therapy: a population-based cohort study. Arthritis Research & Therapy. 20(1). 243–243. 45 indexed citations

8.

Roughley, Matthew, John Belcher, Christian Mallen, & Edward Roddy. (2015). Gout and risk of chronic kidney disease and nephrolithiasis: meta-analysis of observational studies. Arthritis Research & Therapy. 17(1). 90–90. 153 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact